A research team at the Nanyang Technological University (NTU) in Singapore has developed a new biomaterial to ...
Professor Ho Yin Edwin Chan from the School of Life Sciences of The Chinese University of Hong Kong (CUHK), in coll...
An international team of researchers has taken an important step toward understanding a powerful potential treatment for...
Illumina, Inc., the global leader in DNA sequencing and array-based technologies, has announced that it has united with ...
UK-based startup Lifebit Biotech Ltd has announced that it has been awarded a four-year contract by Hong Kong Genome Ins...
The SingHealth Duke-NUS Academic Medical Centre (AMC) has announced the launch of a research institute and disease centr...
A group of researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University in the US, has...
An international research team led by NTU Singapore has proposed a new holistic way of understanding infection...
Researchers from the Centre for Advanced 2D Materials (CA2DM) at the National University of Singapore (NUS) ha...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, ...
Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singa...
A research team led by Professor Dong-Woo Cho and Minjun Ahn of the Pohang University of Science and Technology or POSTE...
Nexturn Bio Inc., a subsidiary of South Korea based Nexturn Bioscience Co., Ltd., has selected its first technological i...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development ...
A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellula...
Taiwanese firm HCmed has announced the start of a strategic partnership with global biotherapeutics leader CSL Behring, ...
EdiGene, Inc. has announced the successful completion of an RMB 400 million (approximately USD 62 million) Series B Plus...
